The Surprising Link Between ADHD and Obesity

Don't let it get away!

Keep track of the stocks that matter to you.

Help yourself with the Fool's FREE and easy new watchlist service today.

A new long-term study of men with attention-deficit/hyperactivity disorder, or ADHD, has linked the disorder with an increased likelihood of becoming obese in adulthood.

The study tracked men with ADHD for more than 30 years and found that a whopping 41% of them were obese compared to 22% of patients in a matched control group who didn't have ADHD. The control group pretty accurately matches the general population, arguing there's something special about the high rate of obesity in men with ADHD.

The obvious explanation is that patients with ADHD have a hard time with impulse control. If you can't resist being the class clown, it's hard to resist eating that extra cookie.

Interestingly adults that had controlled their ADHD symptoms as an adult seemed to have a higher rate of obesity than those that continued to have symptoms. The results could simply be because the study was small -- there were only 111 in the ADHD group -- or it's possible those that have controlled their symptoms have developed a coping mechanism that involves overeating to stimulate the dopamine receptors.

Investment opportunity?
The men in this study were 41, so they were kids in the 1970s, long before drugs such as Pfizer's (NYSE: PFE  ) Quillivant XR, Eli Lilly's (NYSE: LLY  ) Strattera, Johnson & Johnson's (NYSE: JNJ  ) Concerta, or Shire's (NASDAQ: SHPG  ) multitude of ADHD drugs were available to treat the disease.

It seems reasonable to assume that if adolescence could control their ADHD, it might decrease their desire to overeat. There's some evidence for this hypothesis from another study that found children with ADHD who weren't taking medication were 1.5 times as likely to be overweight than those who took ADHD medications.

Companies that sell ADHD medications are in a constant battle with groups that think that children are being over-diagnosed and over-medicated. Avoiding obesity would add arsenal to the argument that treating with drugs is a better choice.

Of course, the companies have to be careful to not overstep their marketing. Side effects for some ADHD medications include reduced appetite and weight loss, which might explain why medicating reduces the likelihood of being overweight. But they're not approved to be used to treat obesity, so the companies aren't allowed to promote them for that purpose. In the fourth quarter of last year, Shire took a $57.5 million charge to settle an investigation of Shire's marketing practices for its ADHD drugs, although it didn't detail exactly what practices the Department of Justice wasn't happy about.

If all else fails, there are drugs actually approved to treat obesity
VIVUS and Arena Pharmaceuticals are in a battle to capture the obesity market with their recently launched drugs. If you're in the dark, grab copies of The Motley Fool's premium research reports on VIVUS and Arena Pharmaceuticals to stay up to date. The reports give investors the must-know information, including an in-depth look at the obesity market and reasons to buy and sell both stocks. Click now for an exclusive look at Arena and VIVUS -- complete with a full year of free updates -- today.

Read/Post Comments (2) | Recommend This Article (3)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On May 21, 2013, at 6:45 PM, pantograph wrote:

    It seems very likely that a poor diet, loaded with wheat, high omega-6 oils, sugar & HFCS, and low in badly needed micronutrients is behind both the epidemics of ADHD and obesity. Of course, big pharma will make huge profits on drugs that attempt to cover up the symptoms without fixing the underlying problem. At least a few people are now getting wise. Sadly the rest of the population is looking for the magic pill which will just contribute to the explosion in health care costs.

  • Report this Comment On May 22, 2013, at 11:48 PM, Beanfarmer wrote:

    I don't buy into it. Both my brother and my son were diagnosed as children. Neither are obese.

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2444993, ~/Articles/ArticleHandler.aspx, 9/29/2016 1:36:54 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,157.32 -181.92 -0.99%
S&P 500 2,154.57 -16.80 -0.77%
NASD 5,275.79 -42.76 -0.80%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/29/2016 1:21 PM
JNJ $117.25 Down -2.14 -1.79%
Johnson and Johnso… CAPS Rating: *****
PFE $33.47 Down -0.52 -1.53%
Pfizer CAPS Rating: ****
SHPG $194.67 Down -4.90 -2.46%
Shire CAPS Rating: ****
ARNA $1.79 Up +0.02 +1.13%
Arena Pharmaceutic… CAPS Rating: ***
LLY $79.35 Down -1.37 -1.69%
Eli Lilly and Co. CAPS Rating: ***
VVUS $1.15 Down -0.02 -1.71%
VIVUS CAPS Rating: **